Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis

J Twiss1, A W Stewart, C A Byrnes

  • 1Starship Children's Hospital, Private Bag 92024, Auckland, New Zealand. jtwiss@ihug.co.nz

Thorax
|February 10, 2006
PubMed

Insights

Children with bronchiectasis (BX) experience significant lung function decline over time. This study highlights the need for effective interventions to prevent long-term health issues in pediatric patients with BX.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Limited data exists on the progression of non-cystic fibrosis bronchiectasis (BX) in children.
  • Understanding lung function changes is crucial for prognosis and treatment evaluation in pediatric BX.
  • Comparison with cystic fibrosis (CF) populations can provide valuable insights.

Purpose of the Study:

  • To evaluate the longitudinal changes in lung function in children with bronchiectasis.
  • To identify covariates influencing lung function decline in pediatric BX.
  • To compare the progression of lung function in children with BX to those with CF.

Main Methods:

  • Longitudinal analysis of lung function data (FEV1) in children with BX and CF (n=44 each) over a mean of 5.7 years.
  • Inclusion criteria: >=3 years of lung function data, age 6-15 years at testing, diagnosis via HRCT, sweat tests, and genetic studies.
  • Comparison of analysis strategies ('best annual' vs. 'all data') and reference equations.

Main Results:

  • Children with BX showed a significant decline in FEV1 (1.9% per annum) using the 'best annual' data approach.
  • Post-infectious BX and chronic Haemophilus influenzae infection were associated with more severe disease.
  • Children with CF had a steeper FEV1 decline (-2.9% per annum) compared to BX.

Conclusions:

  • Pediatric bronchiectasis is characterized by significant, progressive airway obstruction.
  • Lung function deterioration occurs irrespective of the analysis method or reference data used.
  • Urgent development of effective interventions is necessary to mitigate morbidity and mortality in adult survivors of childhood BX.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...